Analysis of gene expression profiles in chemotherapy induced peripheral neuropathy
Not Applicable
- Conditions
- Neoplasms
- Registration Number
- KCT0005059
- Lead Sponsor
- Chonnam National University Hospital Hwasun Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Male or female patients receiving chemotherapy, including oxaliplatin, to treat cancer
Eastern Cooperative Oncology Group performance status (ECOG-PS) grade 2 or less
Patients who voluntarily consented to this study
Exclusion Criteria
Pregnant or lactating women
Patients with experience in chemotherapy
Patients diagnosed with carpal tunnel syndrome, spinal stenosis, diabetic neuropathy, or other neuropathy prior to chemotherapy
Patients diagnosed with brain metastasis
Patients on medication for severe depression or mood disorders
Patients judged unsuitable by investigator judgment
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gene expression
- Secondary Outcome Measures
Name Time Method Functional Assessment of Cancer Therapy / Gynecologic Oncology Group-Neurotoxicity;National Cancer Institute-Common Toxicity Criteria (NCI-CTC) scale